Home » Intercell Signs Vaccine Deal With GlaxoSmithKline
Intercell Signs Vaccine Deal With GlaxoSmithKline
Austria’s Intercell said it has signed a strategic alliance with GlaxoSmithKline
to accelerate the development and commercialization of needle-free, patch-based vaccines.
Fox Business
Fox Business
Upcoming Events
-
07May
-
14May
-
30May